Casandra
Casandra Test Code QD61378Version 1 (DRAFT)
Performing Lab
ThinPrep® Imaging Pap and HPV DNA
Clinical Use
Order TestUse
Liquid Based Pap Testing using the ThinPrep® Imaging System is intended for screening and detection of cervical cancer, pre‑cancerous lesions, atypical cells, and all cytologic categories defined by The Bethesda System. The Pap screening component is not reliable for detection of endometrial cancer.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS
Biomarkers
2 components
ThinPrep® Imaging Pap • Clinical ChemistryHPV DNA, High Risk, Cervical • PCR
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Tumor Tissue
Volume
Not provided
Minimum Volume
Not provided
Container
Pap sample collected in 1 ThinPrep® pap vial
Collection Instructions
See instructions in specimen collection and transport guide
Causes for Rejection
Swabs • Cervical swabs in Digene® HC cervical sampler • Digene vials
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 42 days |
| Refrigerated | Unacceptable |
| Frozen | Unacceptable |